PK-11195

PK-11195 is a synthetic molecule of the isoquinoline carboxamide family. It was first synthesized in the 1980s by the French pharmaceutical company Servier, and is most commonly used in scientific research as a reference ligand for the peripheral benzodiazepine receptor, also known as the translocator protein (TSPO).

History

PK-11195 was first synthesized in the 1980s by the French pharmaceutical company Servier. It was initially developed as a potential therapeutic agent for a variety of conditions, including anxiety disorders and epilepsy. However, its clinical development was discontinued due to its poor pharmacokinetic properties and lack of efficacy in clinical trials.

Pharmacology

PK-11195 is a selective ligand for the peripheral benzodiazepine receptor, also known as the translocator protein (TSPO). It binds to the TSPO with high affinity and specificity, and is often used in scientific research as a reference ligand for this protein.

Uses

Although PK-11195 is not used clinically, it is widely used in scientific research. Its primary use is as a reference ligand for the TSPO in studies investigating the role of this protein in various physiological and pathological processes. These include studies on neuroinflammation, neurodegeneration, and the response of the brain to injury and disease.

See also

• Benzodiazepine
• Translocator protein
• Neuroinflammation
• Neurodegeneration

PK-11195 Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski